Beijing Wantai Biological Pharmacy Enterprise Co Ltd

CN

Health Care

66.54 ₽

Current price

Strong sell
66.54 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    898 / 1361

  • Position in country

    6443 / 7387

  • Return on Assets, %

    7.2

    -40.3

  • Net income margin, %

    -34.4

    -180

  • EBITDA margin, %

    -21.9

    -168.2

  • Debt to Equity, %

    2.4

    3.2

  • Intangible assets and goodwill, %

    4

    0.2

  • Revenue CAGR 3Y, %

    32.7

    12.5

  • Total Equity change 1Y, %

    0

    -9

  • Revenue Y, % chg

    -52.9

    0

  • P/E

    78.9

    31

  • P/BV

    7.6

    1.8

  • P/S

    17.7

    10.3

  • EV/S

    16.7

    7.5

  • EV/EBITDA

    77.7

    -1.6

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    -24

    131.1

  • Forward P/E

    26.5

    21.4

  • Dividend Yield, %

    0.9

    1.1

  • Forward Dividend Yield, %

    0

    0.1

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    32.4

    0

Get an analytical review of this company

Competitors

Ranks

  • Imeik Technology Development Co Ltd

    00%

  • Chongqing Zhifei Biological Products Co Ltd

    00%

  • Shanghai RAAS Blood Products Co Ltd

    00%

  • Hualan Biological Engineering Inc

    00%

  • Beijing Tiantan Biological Products Corp Ltd

    00%

  • Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

    00%

  • Akeso Inc

    00%

  • Gan & Lee Pharmaceuticals

    00%

  • Innovent Biologics Inc

    00%

  • Beijing Wantai Biological Pharmacy Enterprise Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Biotechnology

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    13517.4

  • Ticker

    603392.SS

  • ISIN

    CNE100004090

  • IPO date

    2020-04-29

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-28

  • Date fact. publication of reports

    2023-12-31

Company Description

Beijing Wantai Biopharmaceutical Co., Ltd. is a company mainly engaged in the research and development, production and sales of in-vitro diagnostics. The Company produces and sells in-vitro diagnostics, in-vitro diagnostic equipment and vaccines. The Company is also engaged in the sales of agent products. The in-vitro diagnostics include: enzyme-linked immunosorbent assay (ELISA) reagents, chemiluminescence reagents, biochemical reagents and quality control products. The in-vitro diagnostic instruments mainly include the automatic chemiluminescence immunoassay analyzer. The primary product of vaccine products is Hecolin used for hepatitis E. The agent products are in-vitro diagnostics and in-vitro diagnostic equipment from Bio-Rad Laboratories Inc in the U.S. and Diagast SAS in France.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: